10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2013 | |||
Consolidated Statement of Income | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
Sales | $ 44,033 | 47,267 | 48,047 |
Costs, Expenses and Other | |||
Materials and production | 16,954 | 16,446 | 16,871 |
Marketing and administrative | 11,911 | 12,776 | 13,733 |
Research and development | 7,503 | 8,168 | 8,467 |
Restructuring costs | 1,709 | 664 | 1,306 |
Equity income from affiliates | (404) | (642) | (610) |
Other (income) expense, net | 815 | 1,116 | 946 |
Total Costs, Expenses and Other | 38,488 | 38,528 | 40,713 |
Income Before Taxes | 5,545 | 8,739 | 7,334 |
Taxes on Income | 1,028 | 2,440 | 942 |
Net Income | 4,517 | 6,299 | 6,392 |
Less: Net Income Attributable to Noncontrolling Interests | 113 | 131 | 120 |
Net Income Attributable to Merck & Co., Inc. | 4,404 | 6,168 | 6,272 |
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 1.49 | 2.03 | 2.04 |
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 1.47 | 2.00 | 2.02 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2013 | |||
Consolidated Statement of Comprehensive Income | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
Net Income Attributable to Merck & Co., Inc. | $ 4,404 | 6,168 | 6,272 |
Other Comprehensive Income (Loss) Net of Taxes: | |||
Net unrealized gain (loss) on derivatives, net of reclassifications | 229 | (101) | (37) |
Net unrealized (loss) gain on investments, net of reclassifications | (19) | 52 | (10) |
Benefit plan net gain (loss) and prior service cost (credit), net of amortization | 2,758 | (1,321) | (303) |
Cumulative translation adjustment | (483) | (180) | 434 |
Other comprehensive income (loss), net of taxes | 2,485 | (1,550) | 84 |
Comprehensive Income Attributable to Merck & Co., Inc. | 6,889 | 4,618 | 6,356 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2013 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
Cash Flows from Operating Activities | |||
Net income | $ 4,517 | 6,299 | 6,392 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation and amortization | 6,988 | 6,978 | 7,427 |
Intangible asset impairment charges | 765 | 200 | 705 |
Gain on disposition of interest in equity method investment | 0 | 0 | (136) |
Equity income from affiliates | (404) | (642) | (610) |
Dividends and distributions from equity affiliates | 237 | 291 | 216 |
Deferred income taxes | (330) | 669 | (1,537) |
Share-based compensation | 276 | 335 | 369 |
Other | 399 | 28 | 323 |
Net changes in assets and liabilities: | |||
Accounts receivable | 436 | 349 | (1,168) |
Inventories | (365) | (482) | (678) |
Trade accounts payable | 522 | (302) | 182 |
Accrued and other current liabilities | (397) | (717) | 1,444 |
Income taxes payable | (1,421) | (34) | (277) |
Noncurrent liabilities | (132) | (1,747) | (7) |
Other | 563 | (1,203) | (262) |
Net Cash Provided by Operating Activities | 11,654 | 10,022 | 12,383 |
Cash Flows from Investing Activities | |||
Capital expenditures | (1,548) | (1,954) | (1,723) |
Purchases of securities and other investments | (17,991) | (12,841) | (7,325) |
Proceeds from sales of securities and other investments | 16,298 | 7,783 | 6,149 |
Proceeds from sale of interest in equity method investment | 0 | 0 | 175 |
Acquisitions of businesses, net of cash acquired | (246) | 0 | (373) |
Dispositions of businesses, net of cash divested | 46 | 0 | 323 |
Cash inflows (outflows) from net investment hedges | 350 | 39 | (86) |
Other | (57) | 168 | (30) |
Net Cash Used in Investing Activities | (3,148) | (6,805) | (2,890) |
Cash Flows from Financing Activities | |||
Net change in short-term borrowings | (159) | 624 | 1,076 |
Payments on debt | (1,775) | (22) | (1,547) |
Proceeds from issuance of debt | 6,467 | 2,562 | 0 |
Purchases of treasury stock | (6,516) | (2,591) | (1,921) |
Dividends paid to stockholders | (5,157) | (5,116) | (4,691) |
Other dividends paid | (120) | (120) | (120) |
Proceeds from exercise of stock options | 1,210 | 1,310 | 321 |
Other | 60 | 86 | (22) |
Net Cash Used in Financing Activities | (5,990) | (3,267) | (6,904) |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | (346) | (30) | 42 |
Net Increase (Decrease) in Cash and Cash Equivalents | 2,170 | (80) | 2,631 |
Cash and Cash Equivalents at Beginning of Year | 13,451 | 13,531 | |
Cash and Cash Equivalents at End of Year | 15,621 | 13,451 | 13,531 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
MERCK & CO., INC. | ||
Ticker: MRK Fiscal Year: 2013 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2013 10-K (Filed: Feb 27, 2014) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2013 | Dec 31, 2012 | |
Assets | ||
Current Assets | ||
Cash and cash equivalents | $ 15,621 | 13,451 |
Short-term investments | 1,865 | 2,690 |
Accounts receivable (net of allowance for doubtful accounts of $146 in 2013 and $163 in 2012) (excludes accounts receivable of $275 in 2013 and $473 in 2012 classified in Other assets - see Note 5) | 7,184 | 7,672 |
Inventories (excludes inventories of $1,704 in 2013 and $1,606 in 2012 classified in Other assets - see Note 6) | 6,226 | 6,535 |
Deferred income taxes and other current assets | 4,789 | 4,509 |
Total current assets | 35,685 | 34,857 |
Investments | 9,770 | 7,305 |
Property, Plant and Equipment (at cost) | ||
Land | 550 | 591 |
Buildings | 13,627 | 13,196 |
Machinery, equipment and office furnishings | 17,106 | 17,188 |
Construction in progress | 1,811 | 2,440 |
Property, Plant and Equipment, Gross | 33,094 | 33,415 |
Less: accumulated depreciation | 18,121 | 17,385 |
Property, Plant and Equipment, Net, Total | 14,973 | 16,030 |
Goodwill | 12,301 | 12,134 |
Other Intangibles, Net | 23,801 | 29,083 |
Other Assets | 9,115 | 6,723 |
Total Assets | 105,645 | 106,132 |
Liabilities and Equity | ||
Current Liabilities | ||
Loans payable and current portion of long-term debt | 4,521 | 4,315 |
Trade accounts payable | 2,274 | 1,753 |
Accrued and other current liabilities | 9,501 | 9,737 |
Income taxes payable | 251 | 1,200 |
Dividends payable | 1,321 | 1,343 |
Total current liabilities | 17,868 | 18,348 |
Long-Term Debt | 20,539 | 16,254 |
Deferred Income Taxes | 6,776 | 5,740 |
Other Noncurrent Liabilities | 8,136 | 10,327 |
Merck & Co., Inc. Stockholders Equity | ||
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2013 and 2012 | 1,788 | 1,788 |
Other paid-in capital | 40,508 | 40,646 |
Retained earnings | 39,257 | 39,985 |
Accumulated other comprehensive loss | (2,197) | (4,682) |
Stockholders' equity before deduction for treasury stock | 79,356 | 77,737 |
Less treasury stock, at cost: 649,576,808 shares in 2013 and 550,468,221 shares in 2012 | 29,591 | 24,717 |
Total Merck & Co., Inc. stockholders equity | 49,765 | 53,020 |
Noncontrolling Interests | 2,561 | 2,443 |
Total equity | 52,326 | 55,463 |
Total Liabilities and Equity | 105,645 | 106,132 |
External Links | |
MERCK & CO., INC. (MRK) Fiscal Year 2013 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |